Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03709667 · ClinicalTrials.gov registry record · Early Phase 1
Exercise in Methamphetamine Use Disorder Upregulation and Neural Function
A Early Phase 1 study of Methamphetamine Abuse, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 113
- Enrollment target
- 1
- Study location
NCT03709667 is a Early Phase 1 study of Methamphetamine Abuse that has completed, run by University of California, Los Angeles. The registered enrollment target is 113 participants, below the 201-participant average among 15 other Methamphetamine Abuse trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03709667, a Early Phase 1 study of Methamphetamine Abuse, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 113 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to determine the effects of an exercise intervention and health-education program on brain dopamine receptors and on cognitive functions that have been linked to these receptors.
Conditions Studied
Interventions
- BEHAVIORAL EX
- BEHAVIORAL CON
Study Locations (1)
California
- University of California Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2019-06-26 |
| Est. Completion | 2023-08-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03709667
The ClinicalTrials.gov registry entry for NCT03709667 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 201-participant average among 15 other Methamphetamine Abuse trials with a reported enrollment target (44% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Methamphetamine Abuse appearing as the primary indexed condition, and to 2 interventions - of which EX is the first listed.
NCT03709667 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03709667 about?
NCT03709667 is a clinical study titled "Exercise in Methamphetamine Use Disorder Upregulation and Neural Function". The purpose of this research study is to determine the effects of an exercise intervention and health-education program on brain dopamine receptors and on cognitive functions that have been linked to these receptors.
What is the current status of trial NCT03709667?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 113 participants. The study started on 2019-06-26. Estimated completion is 2023-08-30.
What conditions does trial NCT03709667 study?
This clinical trial studies the following conditions: Methamphetamine Abuse.
What interventions are being tested in trial NCT03709667?
The interventions under investigation include: EX (BEHAVIORAL), CON (BEHAVIORAL).
Who is sponsoring clinical trial NCT03709667?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03709667 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Methamphetamine Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Targeting GABA and Opioid Systems for a Pharmacotherapy for Methamphetamine Abuse
COMPLETED · Early Phase 1
-
A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine
RECRUITING · Phase 2
-
Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder
RECRUITING · Phase 3
-
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
RECRUITING · NA
-
Theta Burst TMS for Treatment of Methamphetamine Use Disorder
RECRUITING · NA
-
rTMS for Craving in Methamphetamine Use Disorder
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.